Skip to main content
. 2017 Jul 27;4(3):ofx158. doi: 10.1093/ofid/ofx158

Figure 1.

Figure 1.

Sustained virologic response 12 weeks after end of therapy (SVR12) according to cirrhosis status and CD4 T-cell count (/µL).